Literature DB >> 11950785

Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression.

Mingxing Xie1, Dongfang Yang, Lan Liu, Bob Xue, Bingfang Yan.   

Abstract

Carboxylesterases hydrolyze numerous endogenous and foreign compounds with diverse structures. Humans and rodents express multiple forms of carboxylesterases, which share a high degree of sequence identity (approximately 70%). Alignment analyses locate in carboxylesterases several functional subsites such the catalytic triad as seen in acetylcholinesterase. The aim of this study was to determine among human and rodent carboxylesterases the immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, tissue distribution, and tumor-related expression. Six antibodies against whole carboxylesterases or synthetic peptides were tested for their reactivity toward 11 human or rodent recombinant carboxylesterases. The antibodies against whole proteins generally exhibited a broader cross-reactivity than the anti-peptide antibodies. All carboxylesterases hydrolyzed para-nitrophenylacetate and para-nitrophenylbutyrate. However, the relative activity varied markedly from enzyme to enzyme (>20-fold), and some carboxylesterases showed a clear substrate preference. Carboxylesterases with the same functional subsites had a similar profile on substrate specificity and sensitivity toward phenylmethylsulfonyl fluoride (PMSF) and paraoxon, suggesting that these subsites play determinant roles in the recognition of substrates and inhibitors. Among three human carboxylesterases, HCE-1 hydrolyzed both substrates to a similar extent, whereas HCE-2 and HCE-3 showed an opposite substrate preference. All three enzymes were inhibited by PMSF and paraoxon, but they showed a marked difference in relative sensitivities. Based on immunoblotting analyses, HCE-1 was present in all tissues examined, whereas HCE-2 and HCE-3 were expressed in a tissue-restricted pattern. Colon carcinomas expressed slightly higher levels of HCE-1 and HCE-2 than the adjacent normal tissues, whereas the opposite was true with HCE-3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950785     DOI: 10.1124/dmd.30.5.541

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  19 in total

1.  Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo.

Authors:  T Nie; C C Wong; N Alston; P Aro; P P Constantinides; B Rigas
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: postnatal surge and organ-dependent regulation.

Authors:  Yi-Tzai Chen; Lynnie Trzoss; Dongfang Yang; Bingfang Yan
Journal:  Toxicology       Date:  2015-02-24       Impact factor: 4.221

3.  Pharmacokinetics, metabolism, bioavailability, tissue distribution and excretion studies of 16α-hydroxycleroda-3, 13(14) Z -dien-15, 16-olide-a novel HMG-CoA reductase inhibitor.

Authors:  Tulsankar Sachin Laxman; Santosh Kumar Puttrevu; Rajesh Pradhan; Anjali Mishra; Sarvesh Verma; Yashpal S Chhonker; Swarnim Srivastava; Suriya P Singh; Koneni V Sashidhara; Rabi Sankar Bhatta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-06       Impact factor: 3.000

4.  Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.

Authors:  Chi C Wong; Ka-Wing Cheng; Gang Xie; Dingying Zhou; Cai-Hua Zhu; Panayiotis P Constantinides; Basil Rigas
Journal:  J Pharmacol Exp Ther       Date:  2011-11-15       Impact factor: 4.030

5.  Inhibition of Human Liver Carboxylesterase (hCE1) by Organophosphate Ester Flame Retardants and Plasticizers: Implications for Pharmacotherapy.

Authors:  Allison L Phillips; Heather M Stapleton
Journal:  Toxicol Sci       Date:  2019-07-03       Impact factor: 4.849

6.  DNA binding, but not interaction with Bmal1, is responsible for DEC1-mediated transcription regulation of the circadian gene mPer1.

Authors:  Yuxin Li; Xiulong Song; Yuzhong Ma; Jirong Liu; Dongfang Yang; Bingfang Yan
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

7.  The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studies.

Authors:  Dingying Zhou; Ioannis Papayannis; Gerardo G Mackenzie; Ninche Alston; Nengtai Ouyang; Liqun Huang; Ting Nie; Chi C Wong; Basil Rigas
Journal:  Carcinogenesis       Date:  2013-01-21       Impact factor: 4.944

8.  The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter.

Authors:  Y Li; M Xie; J Yang; D Yang; R Deng; Y Wan; B Yan
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

9.  Pyrethroid insecticides: isoform-dependent hydrolysis, induction of cytochrome P450 3A4 and evidence on the involvement of the pregnane X receptor.

Authors:  Dongfang Yang; Xiliang Wang; Yi-Tzai Chen; Ruitang Deng; Bingfang Yan
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-26       Impact factor: 4.219

10.  Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system.

Authors:  Gerhard Hoffmann; Christoph Funk; Stephen Fowler; Michael B Otteneder; Alexander Breidenbach; Craig R Rayner; Tom Chu; Eric P Prinssen
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.